Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study.
Rajagopalan, Ashray Aroori, Somaiah Russell, Thomas B Labib, Peter L Ausania, Fabio Pando, Elizabeth Roberts, Keith J Kausar, Ambareen Mavroeidis, Vasileios K Marangoni, Gabriele
Rajagopalan, Ashray
Aroori, Somaiah
Russell, Thomas B
Labib, Peter L
Ausania, Fabio
Pando, Elizabeth
Roberts, Keith J
Kausar, Ambareen
Mavroeidis, Vasileios K
Marangoni, Gabriele
Abstract
Diabetes mellitus (DM) has a complex relationship with pancreatic cancer. This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).
MIDER Authors
Affiliations
University Hospitals Coventry and Warwickshire NHS Trust; University Hospitals Birmingham NHS Foundation Trust
Citations
Altmetric:
Date
2024-04-26
Type
Article
Subject
Collections
Citation
HPB (Oxford) . 2024 Aug;26(8):981-989